. This is a potential hazard to elderly arteriosclerotic patients and is one reason why the drug should not be used in Parkinson's disease unless its value is clear.
(3) In 1958 a diabetic with Parkinson's disease showed improvement of both condi' tions when started on Tolbutamide (Gates and Hyman, 1958) , and these authors late1 found that cases of Parkinson's disease without diabetes also improved. A subsequefl1 double-blind trial did not confirm this (Heller, Dejong and Magee, 1961) .
(4) Dresel and Lewy (1921) described lesions in the globus pallidus in four diabetic5 who died in diabetic coma. Bodechtel and Erbsloh (1958) agree that changes do occ^ in the globus pallidus in diabetes, but suggest that they are not specific for diabeteft and are found elsewhere in the brain. 
